In a report released today, Benjamin Theurer from Barclays maintained a Buy rating on Nutrien (NTR – Research Report), with a price target of $68.00. The company’s shares closed last Friday at $58.17.
Theurer covers the Consumer Defensive sector, focusing on stocks such as Coca Cola Femsa SAB De CV, Beyond Meat, and Pilgrim’s Pride. According to TipRanks, Theurer has an average return of 5.7% and a 55.87% success rate on recommended stocks.
Currently, the analyst consensus on Nutrien is a Moderate Buy with an average price target of $66.20, a 13.80% upside from current levels. In a report released on May 10, Wells Fargo also maintained a Buy rating on the stock with a $68.00 price target.
The company has a one-year high of $67.21 and a one-year low of $47.41. Currently, Nutrien has an average volume of 1.97M.
Based on the recent corporate insider activity of 22 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of NTR in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Nutrien (NTR) Company Description:
Canada-based Nutrien Ltd. is a crop nutrient company, which produces and distributes potash, nitrogen and phosphate products for agricultural, industrial and feed manufacturers.
